 | • レポートコード：GIR-23F3874 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Ophthalmology Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の眼科薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 眼科薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏 アプリケーション別セグメントは次のように区分されます。 ・病院、薬局 世界の眼科薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Allergan、Aerie Pharmaceuticals、Pfizer、Valeant、Bayer、Genentech、Novartis、Regeneron、Takeda、Santen Pharmaceutical 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 眼科薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、薬局 - 世界の眼科薬市場規模・予測 - 世界の眼科薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Allergan、Aerie Pharmaceuticals、Pfizer、Valeant、Bayer、Genentech、Novartis、Regeneron、Takeda、Santen Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏 ・アプリケーション別分析2017年-2028年：病院、薬局 ・眼科薬の北米市場分析 - 眼科薬の北米市場：タイプ別市場規模2017年-2028年 - 眼科薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・眼科薬のヨーロッパ市場分析 - ：眼科薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：眼科薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・眼科薬のアジア太平洋市場分析 - 眼科薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 眼科薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・眼科薬の南米市場分析 - 眼科薬の南米市場：タイプ別市場規模2017年-2028年 - 眼科薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・眼科薬の中東・アフリカ市場分析 - 眼科薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 眼科薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Ophthalmology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ophthalmology Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Ophthalmology Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Gels segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Ophthalmology Drugs include Allergan, Aerie Pharmaceuticals, Pfizer, Valeant, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ophthalmology Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments
Market segment by Application can be divided into
Hospital
Retail Pharmacy
The key market players for global Ophthalmology Drugs market are listed below:
Allergan
Aerie Pharmaceuticals
Pfizer
Valeant
Bayer
Genentech
Novartis
Regeneron
Takeda
Santen Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmology Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ophthalmology Drugs, with price, sales, revenue and global market share of Ophthalmology Drugs from 2019 to 2022.
Chapter 3, the Ophthalmology Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmology Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ophthalmology Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ophthalmology Drugs.
Chapter 13, 14, and 15, to describe Ophthalmology Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ophthalmology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ophthalmology Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.2.6 Ointments
1.3 Market Analysis by Application
1.3.1 Overview: Global Ophthalmology Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Ophthalmology Drugs Market Size & Forecast
1.4.1 Global Ophthalmology Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Ophthalmology Drugs Sales in Volume (2017-2028)
1.4.3 Global Ophthalmology Drugs Price (2017-2028)
1.5 Global Ophthalmology Drugs Production Capacity Analysis
1.5.1 Global Ophthalmology Drugs Total Production Capacity (2017-2028)
1.5.2 Global Ophthalmology Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ophthalmology Drugs Market Drivers
1.6.2 Ophthalmology Drugs Market Restraints
1.6.3 Ophthalmology Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Ophthalmology Drugs Product and Services
2.1.4 Allergan Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Aerie Pharmaceuticals
2.2.1 Aerie Pharmaceuticals Details
2.2.2 Aerie Pharmaceuticals Major Business
2.2.3 Aerie Pharmaceuticals Ophthalmology Drugs Product and Services
2.2.4 Aerie Pharmaceuticals Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Ophthalmology Drugs Product and Services
2.3.4 Pfizer Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Valeant
2.4.1 Valeant Details
2.4.2 Valeant Major Business
2.4.3 Valeant Ophthalmology Drugs Product and Services
2.4.4 Valeant Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Ophthalmology Drugs Product and Services
2.5.4 Bayer Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business
2.6.3 Genentech Ophthalmology Drugs Product and Services
2.6.4 Genentech Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Ophthalmology Drugs Product and Services
2.7.4 Novartis Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Ophthalmology Drugs Product and Services
2.8.4 Regeneron Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Ophthalmology Drugs Product and Services
2.9.4 Takeda Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Santen Pharmaceutical
2.10.1 Santen Pharmaceutical Details
2.10.2 Santen Pharmaceutical Major Business
2.10.3 Santen Pharmaceutical Ophthalmology Drugs Product and Services
2.10.4 Santen Pharmaceutical Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Ophthalmology Drugs Breakdown Data by Manufacturer
3.1 Global Ophthalmology Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Ophthalmology Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Ophthalmology Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Ophthalmology Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Ophthalmology Drugs Manufacturer Market Share in 2021
3.5 Global Ophthalmology Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Ophthalmology Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ophthalmology Drugs Market Size by Region
4.1.1 Global Ophthalmology Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Ophthalmology Drugs Revenue by Region (2017-2028)
4.2 North America Ophthalmology Drugs Revenue (2017-2028)
4.3 Europe Ophthalmology Drugs Revenue (2017-2028)
4.4 Asia-Pacific Ophthalmology Drugs Revenue (2017-2028)
4.5 South America Ophthalmology Drugs Revenue (2017-2028)
4.6 Middle East and Africa Ophthalmology Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Ophthalmology Drugs Sales in Volume by Type (2017-2028)
5.2 Global Ophthalmology Drugs Revenue by Type (2017-2028)
5.3 Global Ophthalmology Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Ophthalmology Drugs Sales in Volume by Application (2017-2028)
6.2 Global Ophthalmology Drugs Revenue by Application (2017-2028)
6.3 Global Ophthalmology Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Ophthalmology Drugs Sales by Type (2017-2028)
7.2 North America Ophthalmology Drugs Sales by Application (2017-2028)
7.3 North America Ophthalmology Drugs Market Size by Country
7.3.1 North America Ophthalmology Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Ophthalmology Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Ophthalmology Drugs Sales by Type (2017-2028)
8.2 Europe Ophthalmology Drugs Sales by Application (2017-2028)
8.3 Europe Ophthalmology Drugs Market Size by Country
8.3.1 Europe Ophthalmology Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Ophthalmology Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Ophthalmology Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Ophthalmology Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Ophthalmology Drugs Market Size by Region
9.3.1 Asia-Pacific Ophthalmology Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Ophthalmology Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Ophthalmology Drugs Sales by Type (2017-2028)
10.2 South America Ophthalmology Drugs Sales by Application (2017-2028)
10.3 South America Ophthalmology Drugs Market Size by Country
10.3.1 South America Ophthalmology Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Ophthalmology Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ophthalmology Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Ophthalmology Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Ophthalmology Drugs Market Size by Country
11.3.1 Middle East & Africa Ophthalmology Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Ophthalmology Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Ophthalmology Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Ophthalmology Drugs
12.3 Ophthalmology Drugs Production Process
12.4 Ophthalmology Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Ophthalmology Drugs Typical Distributors
13.3 Ophthalmology Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Ophthalmology Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Ophthalmology Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Ophthalmology Drugs Product and Services
Table 6. Allergan Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Aerie Pharmaceuticals Major Business
Table 9. Aerie Pharmaceuticals Ophthalmology Drugs Product and Services
Table 10. Aerie Pharmaceuticals Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Ophthalmology Drugs Product and Services
Table 14. Pfizer Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Valeant Basic Information, Manufacturing Base and Competitors
Table 16. Valeant Major Business
Table 17. Valeant Ophthalmology Drugs Product and Services
Table 18. Valeant Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Ophthalmology Drugs Product and Services
Table 22. Bayer Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Genentech Basic Information, Manufacturing Base and Competitors
Table 24. Genentech Major Business
Table 25. Genentech Ophthalmology Drugs Product and Services
Table 26. Genentech Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Ophthalmology Drugs Product and Services
Table 30. Novartis Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Regeneron Basic Information, Manufacturing Base and Competitors
Table 32. Regeneron Major Business
Table 33. Regeneron Ophthalmology Drugs Product and Services
Table 34. Regeneron Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Takeda Basic Information, Manufacturing Base and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Ophthalmology Drugs Product and Services
Table 38. Takeda Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Santen Pharmaceutical Major Business
Table 41. Santen Pharmaceutical Ophthalmology Drugs Product and Services
Table 42. Santen Pharmaceutical Ophthalmology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Ophthalmology Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Ophthalmology Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Ophthalmology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Ophthalmology Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Ophthalmology Drugs Production Site of Key Manufacturer
Table 48. Ophthalmology Drugs New Entrant and Capacity Expansion Plans
Table 49. Ophthalmology Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Ophthalmology Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Global Ophthalmology Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Global Ophthalmology Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Ophthalmology Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Ophthalmology Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Global Ophthalmology Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Global Ophthalmology Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Ophthalmology Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Ophthalmology Drugs Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Ophthalmology Drugs Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Ophthalmology Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Global Ophthalmology Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Global Ophthalmology Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Ophthalmology Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Ophthalmology Drugs Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Ophthalmology Drugs Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Ophthalmology Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Ophthalmology Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Ophthalmology Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Ophthalmology Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Ophthalmology Drugs Sales by Type (2017-2022) & (K Units)
Table 71. North America Ophthalmology Drugs Sales by Type (2023-2028) & (K Units)
Table 72. North America Ophthalmology Drugs Sales by Application (2017-2022) & (K Units)
Table 73. North America Ophthalmology Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Europe Ophthalmology Drugs Sales by Country (2017-2022) & (K Units)
Table 75. Europe Ophthalmology Drugs Sales by Country (2023-2028) & (K Units)
Table 76. Europe Ophthalmology Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Ophthalmology Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Ophthalmology Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Europe Ophthalmology Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Europe Ophthalmology Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Ophthalmology Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Ophthalmology Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Ophthalmology Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Ophthalmology Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Ophthalmology Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Ophthalmology Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Ophthalmology Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Ophthalmology Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Ophthalmology Drugs Sales by Application (2023-2028) & (K Units)
Table 90. South America Ophthalmology Drugs Sales by Country (2017-2022) & (K Units)
Table 91. South America Ophthalmology Drugs Sales by Country (2023-2028) & (K Units)
Table 92. South America Ophthalmology Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Ophthalmology Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Ophthalmology Drugs Sales by Type (2017-2022) & (K Units)
Table 95. South America Ophthalmology Drugs Sales by Type (2023-2028) & (K Units)
Table 96. South America Ophthalmology Drugs Sales by Application (2017-2022) & (K Units)
Table 97. South America Ophthalmology Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Ophthalmology Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Ophthalmology Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Ophthalmology Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Ophthalmology Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Ophthalmology Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Ophthalmology Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Ophthalmology Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Ophthalmology Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Ophthalmology Drugs Raw Material
Table 107. Key Manufacturers of Ophthalmology Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Ophthalmology Drugs Typical Distributors
Table 111. Ophthalmology Drugs Typical Customers
List of Figures
Figure 1. Ophthalmology Drugs Picture
Figure 2. Global Ophthalmology Drugs Revenue Market Share by Type in 2021
Figure 3. Gels
Figure 4. Eye Solutions
Figure 5. Capsules & Tablets
Figure 6. Eye Drops
Figure 7. Ointments
Figure 8. Global Ophthalmology Drugs Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Global Ophthalmology Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Ophthalmology Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Ophthalmology Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Ophthalmology Drugs Price (2017-2028) & (USD/Unit)
Figure 15. Global Ophthalmology Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Ophthalmology Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Ophthalmology Drugs Market Drivers
Figure 18. Ophthalmology Drugs Market Restraints
Figure 19. Ophthalmology Drugs Market Trends
Figure 20. Global Ophthalmology Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Ophthalmology Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Ophthalmology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Ophthalmology Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Ophthalmology Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Ophthalmology Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Ophthalmology Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Ophthalmology Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Ophthalmology Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Ophthalmology Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Ophthalmology Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Ophthalmology Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Ophthalmology Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Ophthalmology Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Ophthalmology Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Ophthalmology Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Ophthalmology Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Ophthalmology Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Ophthalmology Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Ophthalmology Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Ophthalmology Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Ophthalmology Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Ophthalmology Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Ophthalmology Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Ophthalmology Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Ophthalmology Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Ophthalmology Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Ophthalmology Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Ophthalmology Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Ophthalmology Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Ophthalmology Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Ophthalmology Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Ophthalmology Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Ophthalmology Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Ophthalmology Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Ophthalmology Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Ophthalmology Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Ophthalmology Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Ophthalmology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Ophthalmology Drugs in 2021
Figure 79. Manufacturing Process Analysis of Ophthalmology Drugs
Figure 80. Ophthalmology Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
| 【眼科薬について】 眼科薬とは、眼科領域において使用される薬剤の総称であり、眼の病気や疾患の診断、治療、予防に用いられます。眼科薬は、多様な成分を持ち、さまざまな形式で投与されることから、眼科医療において重要な役割を果たしています。以下に、その概念や特徴、種類、用途などについて詳しく述べます。 眼科薬の定義は、主に眼に関連する疾患の治療や管理に特化した薬剤とされます。これには、眼瞼、角膜、網膜、眼内構造、視神経など、眼のさまざまな部分に作用する薬剤が含まれます。また、眼科薬は点眼薬、内服薬、注射薬など、多様な投与経路を持つことが特徴です。 眼科薬の特徴としては、その局所作用が挙げられます。点眼薬が多くは局所に適用されるため、全身的な副作用が少なく、眼の特定の部位に直接効果をもたらすことができます。また、眼科薬は急速に眼組織に吸収されるため、即効性が期待される場合も多いです。さらに、眼科薬の中には、持続的な効果を持つ製品もあり、これによって患者さんの治療負担が軽減されることが期待されています。 眼科薬の種類は多岐にわたります。代表的なものとしては、以下のカテゴリに分けることができます。1つ目は抗菌薬で、細菌感染による眼疾患に対して使用されるもので、点眼薬や軟膏が一般的です。2つ目は抗ウイルス薬で、ウイルス性結膜炎などの治療に用いられます。3つ目は抗真菌薬で、真菌感染による眼の疾患に対応します。 次に、抗炎症薬のグループも重要です。このカテゴリには、非ステロイド性抗炎症薬（NSAIDs）やコルチコステロイドが含まれ、炎症に伴う症状を緩和するために使用されます。例えば、アレルギー性結膜炎やぶどう膜炎などの疾患に対して効果を発揮します。 さらに、眼圧を下げるための緑内障治療薬も重要な眼科薬の一つです。これには、プロスタグランジン類似薬やベータ遮断薬が含まれ、眼圧の管理に必要不可欠です。これらの薬剤は、網膜視神経の保護や視力の維持に寄与します。 用途としては、眼科薬は非常に多様です。目の感染症の治療や、慢性的な眼疾患の管理、手術後の合併症予防など、用途は広範囲に渡ります。たとえば、手術後に使用される抗炎症薬や抗菌薬は、術後の回復を助け、合併症を防ぐために必要です。また、白内障手術後に使用される薬剤は、炎症や感染を軽減する目的で処方されます。 さらに、眼科における新しい技術や製品の開発が進んでいます。ドラッグデリバリーシステムの進化により、持続的な薬剤放出が可能になったことは、眼科治療において大きな進展をもたらしています。特に、眼内部に直接投与するインプラント型薬剤や、目薬の新しい処方形式が研究されており、患者さんの利便性を向上させる試みが行われています。 最近では、遺伝子治療や細胞治療など、より革新的なアプローチも眼科領域に取り入れられてきています。これにより、難治性の眼疾患に対する新たな治療法の期待が高まっています。たとえば、中心性漿液性脈絡網膜症や加齢黄斑変性症に対する治療法の開発が進んでおり、治療選択肢が増えることが患者さんにとっては大きな利点となります。 眼科薬の出現により、以前よりも多くの眼疾患が効果的に治療できるようになり、患者さんの生活の質を向上させることが可能になりました。しかし、適切な使用方法や副作用、相互作用についても十分理解することが大切です。患者さんには、医師からの指示に従い、適切な方法で薬剤を使用することが推奨されます。 結論として、眼科薬は眼の疾患の診断、治療、予防において欠かせない存在です。多様な種類とあらゆる投与経路を持つ眼科薬は、眼科医療の重要な一翼を担っています。今後の技術革新によって、さらなる効果的な治療法が提供されることが期待されており、眼科医療の発展に寄与し続けることでしょう。患者さんにとっての希望ともなる眼科薬の進化は、今後も注目されるテーマとなるはずです。 |